In this podcast, Dr Williams speaks with Dr Anastassia Amaro, director of the Obesity and Metabolic Center at Penn, about the new drugs for obesity. The discussion starts with the physiology and pharmacology of both semaglutide and tirzepatide, and then covers the practical aspects of prescribing these drugs to patients.
